Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study
BRAF 和 MEK 抑制剂在转移性黑色素瘤患者中进行类内转换后的耐受性:一项多中心回顾性研究
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15051426
Salzmann, Martin; Wald, Alexander; Stege, Henner; Loquai, Carmen; Zimmer, Lisa; Hayani, Kinan M; Heinzerling, Lucie; Gutzmer, Ralf; Enk, Alexander H; Hassel, Jessica C